Clinical acceptance of antimicrobial photodynamic therapy in the age of WHO global priority pathogens: So what we need to move forward?

Detalles Bibliográficos
Autores principales: Sellera, Fábio P., Sabino, Caetano P., Núñez, Silvia C., Ribeiro, Martha S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558772/
https://www.ncbi.nlm.nih.gov/pubmed/36244682
http://dx.doi.org/10.1016/j.pdpdt.2022.103158
_version_ 1784807516131033088
author Sellera, Fábio P.
Sabino, Caetano P.
Núñez, Silvia C.
Ribeiro, Martha S.
author_facet Sellera, Fábio P.
Sabino, Caetano P.
Núñez, Silvia C.
Ribeiro, Martha S.
author_sort Sellera, Fábio P.
collection PubMed
description
format Online
Article
Text
id pubmed-9558772
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-95587722022-10-16 Clinical acceptance of antimicrobial photodynamic therapy in the age of WHO global priority pathogens: So what we need to move forward? Sellera, Fábio P. Sabino, Caetano P. Núñez, Silvia C. Ribeiro, Martha S. Photodiagnosis Photodyn Ther Editorial Elsevier B.V. 2022-12 2022-10-13 /pmc/articles/PMC9558772/ /pubmed/36244682 http://dx.doi.org/10.1016/j.pdpdt.2022.103158 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Editorial
Sellera, Fábio P.
Sabino, Caetano P.
Núñez, Silvia C.
Ribeiro, Martha S.
Clinical acceptance of antimicrobial photodynamic therapy in the age of WHO global priority pathogens: So what we need to move forward?
title Clinical acceptance of antimicrobial photodynamic therapy in the age of WHO global priority pathogens: So what we need to move forward?
title_full Clinical acceptance of antimicrobial photodynamic therapy in the age of WHO global priority pathogens: So what we need to move forward?
title_fullStr Clinical acceptance of antimicrobial photodynamic therapy in the age of WHO global priority pathogens: So what we need to move forward?
title_full_unstemmed Clinical acceptance of antimicrobial photodynamic therapy in the age of WHO global priority pathogens: So what we need to move forward?
title_short Clinical acceptance of antimicrobial photodynamic therapy in the age of WHO global priority pathogens: So what we need to move forward?
title_sort clinical acceptance of antimicrobial photodynamic therapy in the age of who global priority pathogens: so what we need to move forward?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558772/
https://www.ncbi.nlm.nih.gov/pubmed/36244682
http://dx.doi.org/10.1016/j.pdpdt.2022.103158
work_keys_str_mv AT sellerafabiop clinicalacceptanceofantimicrobialphotodynamictherapyintheageofwhoglobalprioritypathogenssowhatweneedtomoveforward
AT sabinocaetanop clinicalacceptanceofantimicrobialphotodynamictherapyintheageofwhoglobalprioritypathogenssowhatweneedtomoveforward
AT nunezsilviac clinicalacceptanceofantimicrobialphotodynamictherapyintheageofwhoglobalprioritypathogenssowhatweneedtomoveforward
AT ribeiromarthas clinicalacceptanceofantimicrobialphotodynamictherapyintheageofwhoglobalprioritypathogenssowhatweneedtomoveforward

Ejemplares similares